Newsletter Subscription


Monday, August 31, 2015


Another Major European Airport Selects Implant Sciences' QS-B220 Explosives and Drugs Trace Detector for Aviation Security

Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has sold and shipped its Quantum Sniffer™ QS-B220 desktop explosives and drugs trace detector to a major European airport. This marks the third major European airport to select the QS-B220 for aviation security within the last four months.

"We are pleased to have won this contract in a competitive bidding situation. Our QS-B220 was selected over competing systems by yet another well-known international European airport," stated Implant Sciences' Vice President of Sales and Marketing, Dr. Darryl Jones. "The customer conducted an extensive trial of the system, during which they we able to evaluate first hand our QS-B220's consistent and positive identification of a broad range of explosives and drugs, as well as the excellent level of local training and support provided by our distributor."


Related Research on ASDReports.com:
Distributed Fibre Optic Sensing (DFOS) Market 2015-2025

Your company’s press release on ASDNews and to thousands of other journalists and editors? Use our ASDWire press release distribution service.

Source : Implant Sciences Corp.

Published on ASDNews: Dec 12, 2012

 

Unmanned Aerial Systems Conference

Nov 19 - 20, 2015 - London, United Kingdom

Register More info


4th Annual SOF Symposium

Oct 26 - 27, 2015 - Alexandria, United States

Register More info


MilSatCom Latin America 2015 Conference

Sep 22 - 23, 2015 - Maceio, Brazil

Register More info


© 2004-2015 • ASDNews • be the first to know • contact usterms & conditionsprivacy policyadvertisingfaqs

zpsk